We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+8.2%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$82.1B
AUM Growth
+$7.21B
Cap. Flow
+$2.14B
Cap. Flow %
2.6%
Top 10 Hldgs %
34.14%
Holding
3,101
New
616
Increased
843
Reduced
896
Closed
659

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$495M
2
SPOT icon
Spotify
SPOT
+$377M
3
HUM icon
Humana
HUM
+$350M
4
GS icon
Goldman Sachs
GS
+$324M
5
MRK icon
Merck
MRK
+$307M

Sector Composition

Rank Sector Weight
1 Technology 18.11%
2 Consumer Discretionary 14.61%
3 Healthcare 12.89%
4 Industrials 6.78%
5 Financials 6.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HCI icon
501
HCI Group
HCI
$2.28B
$19.7M 0.02%
183,565
+82,377
+81% +$7.81M
ACLS icon
502
Axcelis
ACLS
$4.12B
$19.5M 0.02%
185,672
+165,021
+799% +$19.3M
IBN icon
503
ICICI Bank
IBN
$106B
$19.4M 0.02%
650,946
-1,479,886
-69% -$43.1M
XPRO icon
504
Expro Ltd
XPRO
$1.79B
$19.3M 0.02%
1,122,102
-589,623
-34% -$12M
SLG icon
505
SL Green Realty
SLG
$3.88B
$19.2M 0.02%
276,482
+98,511
+55% +$6.32M
MCHP icon
506
Microchip Technology
MCHP
$42.8B
$19.2M 0.02%
+239,479
New +$19.8M
MRVL icon
507
Marvell Technology
MRVL
$174B
$19.1M 0.02%
264,946
-2,215,015
-89% -$153M
SNDX icon
508
Syndax Pharmaceuticals
SNDX
$1.84B
$19.1M 0.02%
989,904
-840,523
-46% -$17.4M
BKD icon
509
Brookdale Senior Living
BKD
$3.62B
$19M 0.02%
2,799,864
+863,083
+45% +$6.16M
HESM icon
510
Hess Midstream
HESM
$5.22B
$18.8M 0.02%
533,554
+328,894
+161% +$12.1M
BRFS
511
DELISTED
BRF SA
BRFS
$18.7M 0.02%
4,288,408
-334,667
-7% -$1.42M
SE icon
512
Sea Limited
SE
$61.2B
$18.6M 0.02%
197,753
-1,159,035
-85% -$87.5M
BHVN icon
513
Biohaven
BHVN
$2.16B
$18.6M 0.02%
371,669
+266,101
+252% +$10.4M
TSLA icon
514
PUT
Tesla
TSLA
$1.24T
$18.5M 0.02%
70,600
-537,300
-88% -$123M
AVGO icon
515
PUT
Broadcom
AVGO
$1.82T
$18.5M 0.02%
107,000
-36,000
-25% -$5.77M
GEHC icon
516
GE HealthCare
GEHC
$27.6B
$18.4M 0.02%
196,533
-620,195
-76% -$52.1M
FSLR icon
517
PUT
First Solar
FSLR
$21.8B
$18.4M 0.02%
+73,600
New +$16.6M
NVST icon
518
Envista
NVST
$4.28B
$18.3M 0.02%
928,394
-200,387
-18% -$3.49M
ACAD icon
519
Acadia Pharmaceuticals
ACAD
$4.25B
$18.3M 0.02%
1,188,612
-1,585,741
-57% -$26.5M
GDXJ icon
520
PUT
VanEck Junior Gold Miners ETF
GDXJ
$7.06B
$18.2M 0.02%
373,100
+210,000
+129% +$9.66M
EVER icon
521
EverQuote
EVER
$886M
$18.1M 0.02%
860,130
+395,304
+85% +$9.03M
HON icon
522
Honeywell
HON
$77.1B
$18.1M 0.02%
93,000
-99,402
-52% -$19.3M
PRIM icon
523
Primoris Services
PRIM
$4.69B
$18.1M 0.02%
311,177
-251,848
-45% -$13.4M
AKR icon
524
Acadia Realty Trust
AKR
$2.99B
$18.1M 0.02%
+769,140
New +$16.4M
EXPD icon
525
Expeditors International
EXPD
$22.9B
$18M 0.02%
136,790
-180,987
-57% -$22.2M

Similar funds

Marshall Wace's Q3 2024 Portfolio in Review

As of Q3 2024, Marshall Wace held 3,101 positions worth $82.1B, up 9.6% from $74.9B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Marshall Wace's Q3 2024 filing shows 616 new, 843 increased, 896 reduced and 659 closed positions. Its largest new stake was Texas Instruments: 1,008,812 shares worth $208M. The largest sale was Costco, an estimated $495M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Marshall Wace's largest Q3 2024 buy was Texas Instruments: 1,008,812 shares worth $208M.
  • Marshall Wace added most to Tesla in Q3 2024, an estimated $700M increase.
  • Marshall Wace's biggest Q3 2024 reduction was Costco, cutting an estimated $495M.
  • Marshall Wace fully exited Shopify in Q3 2024, selling an estimated $209M.
  • Marshall Wace's ten largest holdings make up 34% of its $82.1B portfolio in Q3 2024.
  • Marshall Wace opened 616 new positions and closed 659 in Q3 2024.
  • Marshall Wace's portfolio value rose 9.6% quarter-over-quarter to $82.1B.

Based on Marshall Wace's 13F filing for Q3 2024, filed 14 Nov 2024.